Krystal Biotech Inc (KRYS)

SBC to Revenue

11.87%

Quarterly · Period ending:

KRYS logo

KRYS SBC to Revenue

Latest reported11.87%
KRYS Quarterly SBC/Revenue (0.00% → 11.87%)
High-resolution chart · PNG

KRYS sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc SBC to Revenue — Quarterly
Period endingSBC to Revenue
11.8736%
11.6959%
12.8509%
0%
14.7009%
15.2841%
14.6545%
15.8824%
18.7183%
20.5503%
23.3799%
97.1482%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
59.9631%
53.6878%
29.406%
128.1106%
84.9711%
51.1811%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.